HealthMatch

HealthMatch

Connects patients to clinical trials worldwide

Overview

HealthMatch is a digital platform that connects patients with suitable clinical trials worldwide. It maintains a comprehensive database of trials across medical conditions and provides a user-friendly interface for patients to search and enroll. Sponsors and healthcare organizations partner with HealthMatch to find participants, enabling revenue through these partnerships. Unlike generic job-matching sites, HealthMatch focuses on clinical trial recruitment and uses global reach to match patients with appropriate studies efficiently. The company’s goal is to accelerate medical research and the development of new treatments by increasing patient participation in clinical trials.

About HealthMatch

Simplify's Rating
Why HealthMatch is rated
C+
Rated C on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Healthcare

Company Size

11-50

Company Stage

Series C

Total Funding

$25.8M

Headquarters

Sydney, Australia

Founded

2017

Get referred to HealthMatch

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • HealthMatch still markets actively at SCOPE 2025 and updated its site in 2026.
  • LinkedIn listed 11-50 employees in 2026, signaling ongoing operating scale.
  • Persistent trial bottlenecks keep sponsor demand high for faster patient recruitment.

What critics are saying

  • US entrants like Trialbee and Antidote crowd patient-recruitment budgets by 2025.
  • HealthMatch's 100,000 monthly US signups must convert fast or sponsor revenue stalls.
  • If sponsors shift to site-owned registries, HealthMatch becomes a thin matching layer.

What makes HealthMatch unique

  • HealthMatch spans 300 conditions and 3.6 million matches, per 2022 company materials.
  • Manuri Gunawardena built HealthMatch around AI-driven patient profiling and real-time trial matching.
  • Roche direct-trial partnership gave HealthMatch access beyond public registries in 2019.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$25.8M

Below

Industry Average

Funded Over

4 Rounds

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.
Series C Funding Comparison
Below Average

Industry standards

$50M
$6.8M
HealthMatch
$40M
Figma
$50M
Medium
$62M
SeatGeek
$100M
Oura

Benefits

Remote Work Options

Company Equity

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-4%

2 year growth

-4%
Startup Daily
Sep 12th, 2022
Clinical Trials Startup Healthmatch Lands $10 Million Series C

Clinical trials access startup HealthMatch has raised $10 million in Series C. The round was led by the company’s original backer, Folklore Ventures. Paul Bassat’s Square Peg Capital led an $18 million Series B in the Sydney-based startup in December 2020, also invested in the Series C. Square Peg also led a $6 million series A in late 2019. Malcolm and Lucy Turnbull and Tempus Partners are among the previous investors in HealthMatch, which uses machine learning to automate clinical trials for contract research companies

The CEO Magazine
Jul 13th, 2021
Healthmatch receives financing of $25M in venture capital

Officially launched in 2019, HealthMatch has raised A$25 million in venture capital from investors across Australia, the US and Singapore (where the company received the largest local health tech funding round in Australia for 2020), making access to emerging potential treatments much easier for patients.

Recently Posted Jobs

Sign up to get curated job recommendations

HealthMatch is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →